Literature DB >> 1735254

Exercise testing in the evaluation of patients at high risk for complications from lung resection.

R C Morice1, E J Peters, M B Ryan, J B Putnam, M K Ali, J A Roth.   

Abstract

Exercise testing was performed on 37 patients with resectable lung lesions who were deemed inoperable because of any of the following risk factors: (1) FEV1 less than or equal to 40 percent of predicted; (2) radionuclide calculated postlobectomy FEV1 less than or equal to 33 percent of predicted; or (3) arterial PCO2 greater than or equal to 45 mm Hg. The patients who reached a peak level of oxygen consumption during exercise (VO2Peak) of greater than or equal to 15 ml/kg/min were offered surgical treatment. Patients with a VO2Peak of less than 15 ml/kg/min were referred for nonsurgical management and excluded from the study. Eight patients underwent lung resection. Their pulmonary function revealed a severe obstructive lung defect with a group mean predicted FEV1 of 40 +/- 6 percent, an FEV1/FVC ratio of 47 +/- 10, a radionuclide calculated postlobectomy FEV1 of 31 +/- 4 percent, and a mean arterial PCO2 of 44 +/- 6 mm Hg. No relationship was found between each patient's exercise performance and spirometric function. Six of the patients had an uncomplicated postoperative course. Two patients had complications but no patient died as a result of surgery or postoperative complications. All patients were discharged from the hospital within 22 days (mean = 9.8 days). We conclude that exercise testing is a useful complement to conventional cardiopulmonary evaluation used in selecting patients for lung resection.

Entities:  

Mesh:

Year:  1992        PMID: 1735254     DOI: 10.1378/chest.101.2.356

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  15 in total

1.  BTS guidelines: guidelines on the selection of patients with lung cancer for surgery.

Authors: 
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

2.  Predicting length of stay out of hospital following lung resection using preoperative health status measures.

Authors:  Janet A Parsons; Michael R Johnston; Arthur S Slutsky
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

Review 3.  Surgical treatment of non-small-cell lung cancer in octogenarians.

Authors:  Miguel Guerra; Paulo Neves; José Miranda
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-02-08

4.  Effect of therapeutic hyperoxia on maximal oxygen consumption and perioperative risk stratification in chronic obstructive pulmonary disease.

Authors:  Hilary M Womble; Richard M Schwartzstein; Richard P Johnston; David H Roberts
Journal:  Lung       Date:  2012-01-17       Impact factor: 2.584

Review 5.  Preoperative functional workup for patients with advanced lung cancer.

Authors:  Alessandro Brunelli
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

6.  Racial differences in patients' perceptions of debilitated health states.

Authors:  S Cykert; J D Joines; G Kissling; C J Hansen
Journal:  J Gen Intern Med       Date:  1999-04       Impact factor: 5.128

7.  Effect of thoracotomy and lung resection on exercise capacity in patients with lung cancer.

Authors:  A M Nugent; I C Steele; A M Carragher; K McManus; J A McGuigan; J R Gibbons; M S Riley; D P Nicholls
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

Review 8.  Complications of lung resection and exercise capacity: a meta-analysis.

Authors:  Roberto Benzo; George A Kelley; Laura Recchi; Albert Hofman; Frank Sciurba
Journal:  Respir Med       Date:  2007-04-03       Impact factor: 3.415

9.  Clinical relevance of decreased oxygen saturation during 6-min walk test in preoperative physiologic assessment for lung cancer surgery.

Authors:  Tatsuo Nakagawa; Naohisa Chiba; Masao Saito; Yasuto Sakaguchi; Shinya Ishikawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-05-09

10.  Outcomes of lobectomy in 'active' octogenarians with clinical stage I non-small-cell lung cancer.

Authors:  Hiroyuki Ito; Haruhiko Nakayama; Kouzo Yamada; Tomoyuki Yokose; Munetaka Masuda
Journal:  Ann Thorac Cardiovasc Surg       Date:  2014-04-18       Impact factor: 1.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.